Health and Fitness Health and Fitness
Wed, May 9, 2012
[ Wed, May 09th 2012 ] - Market Wire
Hospira Convenes Its 2012 Annual Meeting of Shareholders
[ Wed, May 09th 2012 ] - Market Wire
ProMetic Reports Highlights of its 2012 Annual and Special Meeting of Shareholders
[ Wed, May 09th 2012 ] - Market Wire
Nordion Launches the Gamma Centre of Excellence
[ Wed, May 09th 2012 ] - Market Wire
CEO/CFO Conference Call Series
[ Wed, May 09th 2012 ] - Market Wire
Prana Chief Scientific Advisor to Give Plenary Le .. sium in Stockholm Featuring New Targets and Drugs
[ Wed, May 09th 2012 ] - Market Wire
Vermillion to Present at B. Riley amp;; Co. 13th Annual Investor Conference on May 23, 2012
[ Wed, May 09th 2012 ] - Market Wire
Accuray Unveils Enhanced TomoTherapy Treatment Planning System at ESTRO 31
[ Wed, May 09th 2012 ] - Market Wire
Thoratec Presentation at Bank of America Merrill Lynch Health Care Conference to be Webcast
[ Wed, May 09th 2012 ] - Market Wire
Small Biotechs Like Aastrom Biosciences and Geron Likely to Benefit From New Patent System
[ Wed, May 09th 2012 ] - Market Wire
Biotech Industry a Hotbed of Merger &;; Acquisition Activity
[ Wed, May 09th 2012 ] - Market Wire
Amerigroup Florida Fights Childhood Obesity
[ Wed, May 09th 2012 ] - Market Wire
Varian Medical Systems Redesigns its ProBeama" Proton Therapy User Interface
[ Wed, May 09th 2012 ] - Market Wire
Cytomedix to Host First Quarter 2012 Financial Results Conference Call on Wednesday, May 16, 2012
[ Wed, May 09th 2012 ] - Market Wire
Newly-Published Study Compares SURFAXIN LSa" and .. stablished Model of Respiratory Distress Syndrome
[ Wed, May 09th 2012 ] - Market Wire
Cytokinetics Announces Company Participation and .. Activities in Connection With ALS Awareness Month
[ Wed, May 09th 2012 ] - Market Wire
Thallion and LFB Report Positive Top-Line Results from the Phase II SHIGATEC Trial at 'VTEC 2012'
[ Wed, May 09th 2012 ] - Market Wire
Heska to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
[ Wed, May 09th 2012 ] - Market Wire
Implant Sciences Appoints Dr. Darryl Jones as VP of Sales and Marketing
Tue, May 8, 2012
[ Tue, May 08th 2012 ] - Market Wire
Dynavax Embarks on Transition to Commercialization
[ Tue, May 08th 2012 ] - Market Wire
Hospira to Present at Upcoming Investor Conferences
[ Tue, May 08th 2012 ] - Market Wire
The Law Firm of Levi amp;; Korsinsky, LLP .. Possible Breaches of Fiduciary Duty by the Board
[ Tue, May 08th 2012 ] - Market Wire
Inergetics Receives Initial Purchase Order from West Point
[ Tue, May 08th 2012 ] - Market Wire
Verisante Technology, Inc. Announces Completion of Beta Units
[ Tue, May 08th 2012 ] - Market Wire
Aethlon Medical Reports Undetectable Hepatitis C .. notype 3, and Genotype 5 Patients Treated with He
[ Tue, May 08th 2012 ] - Market Wire
Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
[ Tue, May 08th 2012 ] - Market Wire
Neuralstem Updates ALS Stem Cell Trial Progress
[ Tue, May 08th 2012 ] - Market Wire
West Announces Proposed Private Placement of Senior Debt Securities
[ Tue, May 08th 2012 ] - Market Wire
Echo Therapeutics Symphony tCGM System To Be Profiled on The Doctors Television Show
[ Tue, May 08th 2012 ] - Market Wire
Celsion Corporation to Hold First Quarter 2012 Fi .. Results Conference Call on Tuesday, May 15, 2012
[ Tue, May 08th 2012 ] - Market Wire
AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
[ Tue, May 08th 2012 ] - Market Wire
InspireMD Announces First Quarter 2012 Financial Results
[ Tue, May 08th 2012 ] - Market Wire
Savient Pharmaceuticals Enters Into Definitive Financing and Debt Restructuring Agreements
[ Tue, May 08th 2012 ] - Market Wire
Stereotaxis Reports Improved First Quarter 2012 Financial Results
[ Tue, May 08th 2012 ] - Market Wire
Marina Biotech Announces Worldwide Exclusive Licensing Agreement With Monsanto
[ Tue, May 08th 2012 ] - Market Wire
Calyx Bio-Ventures Inc. Provides Corporate Update
[ Tue, May 08th 2012 ] - Market Wire
Crown Dynamics and Active Forever Solidify Marketing and Sales Agreement
Mon, May 7, 2012
[ Mon, May 07th 2012 ] - Market Wire
Islet Sciences Announces Exclusive License Agreem .. ommercialize an Early Beta Cell Destruction and D
[ Mon, May 07th 2012 ] - Market Wire
Abbott Reaches Settlement Agreement on Depakote
[ Mon, May 07th 2012 ] - Market Wire
Law Office of Brodsky amp;; Smith, LLC Announces Investigation of Kensey Nash Corporation
[ Mon, May 07th 2012 ] - Market Wire
Covance To Present At The R. W. Baird 2012 Growth Stock Conference
[ Mon, May 07th 2012 ] - Market Wire
ProMetic and Hematech Biotherapeutics Close $10 M .. han Drug License and Strategic Manufacturing Deal
[ Mon, May 07th 2012 ] - Market Wire
Hologic Delivers on Its Promise to Provide Innova .. nologies for Gynecologists and Obstetricians at t
[ Mon, May 07th 2012 ] - Market Wire
Enzon and Hisun Announce Strategic Alliance for E .. Linker Technology and Licensing Agreement for PEG
[ Mon, May 07th 2012 ] - Market Wire
Stereotaxis Announces Definitive Agreements to Raise $18.5 Million in Private Placement Financings
[ Mon, May 07th 2012 ] - Market Wire
Celsion Announces ThermoDox(R) Commercial Supply Agreement With Hisun
[ Mon, May 07th 2012 ] - Market Wire
Keryx Biopharmaceuticals Announces Reversion of K .. 1 (Perifosine) License Rights to Aeterna Zentaris
[ Mon, May 07th 2012 ] - Market Wire
Sequenom Announces Participation at the Bank of America Merrill Lynch Health Care Conference
[ Mon, May 07th 2012 ] - Market Wire
BioSpecifics Technologies Corp. Announces Initiation of Phase II Trial for Canine Lipomas
[ Mon, May 07th 2012 ] - Market Wire
Annals of the Rheumatic Diseases Publishes Pivota .. Efficacy and Safety of RAYOS(R) (Delayed-Release
[ Mon, May 07th 2012 ] - Market Wire
Smith amp;; Nephew, Inc. acquires Kalypto .. ing in Negative Pressure Wound Therapy to deliver
[ Mon, May 07th 2012 ] - Market Wire
XTend Medical Corporation (XMDC) Signs Letter of Intent to Purchase JoyFull Genius, Inc.
[ Mon, May 07th 2012 ] - Market Wire
Concord Medical to Report First Quarter 2012 Financial Results on May 21, 2012
[ Mon, May 07th 2012 ] - Market Wire
Concord Medical Holds Investor Day at Chang'an Hospital on May 31, 2012
[ Mon, May 07th 2012 ] - Market Wire
Amarantus BioSciences Issues First Annual CEO Letter to Shareholders
Sat, May 5, 2012
[ Sat, May 05th 2012 ] - Market Wire
CML HealthCare Inc. to Host Annual and Special Meeting of Shareholders on May 9, 2012
[ Sat, May 05th 2012 ] - Market Wire
Comunicado de Prestige Brands acerca de la decisi .. Genomma Lab de retirar su propuesta de adquisicin
Fri, May 4, 2012
[ Fri, May 04th 2012 ] - Market Wire
Aetna Completes $750 Million Bond Offering
[ Fri, May 04th 2012 ] - Market Wire
Abraham, Fruchter & Twersky, LLP Announces Investigation of Assisted Living Concepts, Inc.
[ Fri, May 04th 2012 ] - Market Wire
Amgen to Present at the Baird Growth Stock Conference
[ Fri, May 04th 2012 ] - Market Wire
Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
[ Fri, May 04th 2012 ] - Market Wire
Neurocrine Biosciences To Present At The Deutsche Bank 37th Annual Health Care Conference
[ Fri, May 04th 2012 ] - Market Wire
New Patents Approved in U.S., Canada;; Expansion of Evidence-Based Tools for Mental Health
[ Fri, May 04th 2012 ] - Market Wire
Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference
[ Fri, May 04th 2012 ] - Market Wire
Healthnostics Update on Key Projects
[ Fri, May 04th 2012 ] - Market Wire
BIOLASE Introduces Next Generation Diode Laser, the EPIC 10(TM)
[ Fri, May 04th 2012 ] - Market Wire
Shire to Present Scientific Data Across Range of .. ican Psychiatric Association Annual Meeting May 5
[ Fri, May 04th 2012 ] - Market Wire
Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
[ Fri, May 04th 2012 ] - Market Wire
Express Scripts to Present at Bank of America Merrill Lynch Conference
[ Fri, May 04th 2012 ] - Market Wire
Equity Research on Spectrum Pharmaceuticals Inc. .. Biotechnology Companies Releasing Strong Earnings
[ Fri, May 04th 2012 ] - Market Wire
Novadaq Reports First Quarter 2012 Financial Results
[ Fri, May 04th 2012 ] - Market Wire
VentriPoint 3D Heart Analysis System Approved for Pulmonary Arterial Hypertension in Canada
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
NuVasive to Participate in Investor Events in May 2012
[ Thu, May 03rd 2012 ] - Market Wire
Haemonetics to Present at Bank of America Merrill Lynch 2012 Health Care Conference
[ Thu, May 03rd 2012 ] - Market Wire
Syneron to Present at the 11th Annual JMP Securities Research Conference
[ Thu, May 03rd 2012 ] - Market Wire
Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
[ Thu, May 03rd 2012 ] - Market Wire
Novation Inks Supplier Contract Category Agreemen .. ulse oximetry and rainbow SET Pulse CO-Oximetrya"
[ Thu, May 03rd 2012 ] - Market Wire
Implant Sciences Signs Extension to $6 Million Co .. for Quantum Sniffer Sales to Government of India
[ Thu, May 03rd 2012 ] - Market Wire
Lightlake Therapeutics Inc. Announces Positive Pr .. Trial Results of Binge Eating Disorder Treatment
[ Thu, May 03rd 2012 ] - Market Wire
Ohr Pharmaceutical to Present at ARVO Annual Meeting on May 6, 2012
[ Thu, May 03rd 2012 ] - Market Wire
NuPathe to Report First Quarter 2012 Results and Hold Conference Call on Thursday, May 10, 2012
[ Thu, May 03rd 2012 ] - Market Wire
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
[ Thu, May 03rd 2012 ] - Market Wire
Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference
[ Thu, May 03rd 2012 ] - Market Wire
Oncolytics Biotech Inc. Enters into Sponsorship A .. or Randomized Phase II Study in Colorectal Cancer
[ Thu, May 03rd 2012 ] - Market Wire
GenVec Awarded Grant For RSV Vaccine Program
[ Thu, May 03rd 2012 ] - Market Wire
Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
[ Thu, May 03rd 2012 ] - Market Wire
Paladin Reports First Quarter 2012 Results Achieves Record Revenues
[ Thu, May 03rd 2012 ] - Market Wire
Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
[ Thu, May 03rd 2012 ] - Market Wire
Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
[ Wed, May 02nd 2012 ] - Market Wire
Hill-Rom Announces Third Quarter 2012 Dividend
[ Wed, May 02nd 2012 ] - Market Wire
West Announces Third Quarter 2012 Dividend and Director Retirement
[ Wed, May 02nd 2012 ] - Market Wire
Hanger completes enrollment of WalkAide INSTRIDE clinical trial
[ Wed, May 02nd 2012 ] - Market Wire
Third Largest US Refinery Pioneers Innovative Safety Program
[ Wed, May 02nd 2012 ] - Market Wire
Location Change
[ Wed, May 02nd 2012 ] - Market Wire
Medicare to Cover Transcatheter Heart Valve Procedure
[ Wed, May 02nd 2012 ] - Market Wire
Hamilton Thorne Receives FDA Clearance on Its Multi-Pulse Software for Clinical Applications
[ Wed, May 02nd 2012 ] - Market Wire
Obesity Related Health Care Costs Total $190 Bill .. Orexigen and Human Genome Look to Take Advantage
[ Wed, May 02nd 2012 ] - Market Wire
Arena Pharmaceuticals and VIVUS Look to Cash in on Anti-Obesity Drug Market
[ Wed, May 02nd 2012 ] - Market Wire
Research on CareFusion Corporation and Stryker Corporation -- Medical Instrument Makers Consistent
[ Wed, May 02nd 2012 ] - Market Wire
Enzon Reports First Quarter 2012 Results
[ Wed, May 02nd 2012 ] - Market Wire
Horizon Pharma to Present at the 11th Annual JMP Securities Research Conference
[ Wed, May 02nd 2012 ] - Market Wire
Zogenix Submits New Drug Application (NDA) to U.S .. n (FDA) for Zohydroa" for Treatment of Chronic Pa
[ Wed, May 02nd 2012 ] - Market Wire
Omeros to Present at Deutsche Bank Securities Health Care Conference
[ Wed, May 02nd 2012 ] - Market Wire
VentriPoint Launches Clinical Trial in Pulmonary .. ith Top Pulmonary Hypertension Centres in the Uni
[ Wed, May 02nd 2012 ] - Market Wire
Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012
[ Wed, May 02nd 2012 ] - Market Wire
SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2012 on May 9th
[ Wed, May 02nd 2012 ] - Market Wire
Crown Dynamic's AirWare Labs(R) Selects 3M Filtration Media for Allergy and Travel Products
Tue, May 1, 2012
[ Tue, May 01st 2012 ] - Market Wire
VentriPoint Announces Closing of First Tranche of .. ivate Placement and Increase to Private Placement
[ Tue, May 01st 2012 ] - Market Wire
Universal Health Services, Inc. to Present at the .. Bank Securities 37th Annual Healthcare Conference
[ Tue, May 01st 2012 ] - Market Wire
Harbinger Research Releases Research Report on Vycor Medical, Inc.
[ Tue, May 01st 2012 ] - Market Wire
Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
[ Tue, May 01st 2012 ] - Market Wire
BIOLASE Named as Finalist in the Medical Devices .. egory for TechAmerica High-Tech Innovation Awards
[ Tue, May 01st 2012 ] - Market Wire
Titan Medical Inc. Announces Research Agreement with ARMA Lab at Vanderbilt University
[ Tue, May 01st 2012 ] - Market Wire
Ohr Pharmaceutical Announces Ophthalmic Scientific Advisory Board
[ Tue, May 01st 2012 ] - Market Wire
Amarantus BioSciences to Present at the New York .. ation (NYBA) 21st Annual Meeting on May 2nd, 2012
[ Tue, May 01st 2012 ] - Market Wire
ISTA Pharmaceuticals Reports Positive, Topline Re .. al Trial of BEPOSONE(TM) Nasal Spray for the Trea
[ Tue, May 01st 2012 ] - Market Wire
Horizon Pharma to Host Conference Call and Webcas .. st Quarter 2012 Financial Results on May 10, 2012
[ Tue, May 01st 2012 ] - Market Wire
Aeterna Zentaris to Announce First Quarter 2012 F .. ts and Hold Annual Shareholders Meeting on May 9,
[ Tue, May 01st 2012 ] - Market Wire
Orexigen Therapeutics Schedules May 9, 2012 Webca .. esults for the First Quarter Ended March 31, 2012
[ Tue, May 01st 2012 ] - Market Wire
Techne Corporation Declares Dividend
[ Tue, May 01st 2012 ] - Market Wire
STAAR Surgical to Present at the Deutsche Bank 37th Annual Health Care Conference
[ Tue, May 01st 2012 ] - Market Wire
Delcath To Report Fiscal 2012 First Quarter Results And Conduct Conference Call
[ Tue, May 01st 2012 ] - Market Wire
MillerCoors Reissuing Purchase Order
[ Tue, May 01st 2012 ] - Market Wire
ShangPharma Corporation Files 2011 Annual Report on Form 20-F
[ Tue, May 01st 2012 ] - Market Wire
Inovio Pharmaceuticals Granted U.S. Patent Protec .. nthetic Vaccine for Cervical Dysplasia and Cancer
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Pivotal Therapeutics Announces 2011 Financial Results
[ Mon, Apr 30th 2012 ] - Market Wire
Metropolitan Health Networks to Announce First Quarter 2012 Results
[ Mon, Apr 30th 2012 ] - Market Wire
The Medicines Company to Participate in the Deutsche Bank 37th Annual Healthcare Conference
[ Mon, Apr 30th 2012 ] - Market Wire
Affymax Announces First Quarter 2012 Financial Results Teleconference and Webcast
[ Mon, Apr 30th 2012 ] - Market Wire
Salix Pharmaceuticals Announces Extension of Crofelemer NDA Priority Review
[ Mon, Apr 30th 2012 ] - Market Wire
Ergoresearch Announces Creation of Ergorecherche France
[ Mon, Apr 30th 2012 ] - Market Wire
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Nuvigil
[ Mon, Apr 30th 2012 ] - Market Wire
Five Star Quality Care, Inc. to Present at the Deutsche Bank Healthcare Conference on May 7, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Celsion to Present at the 37th Annual Deutsche Bank Health Care Conference
[ Mon, Apr 30th 2012 ] - Market Wire
St. Jude Medical to Present at the 37th Annual Deutsche Bank Health Care Conference
[ Mon, Apr 30th 2012 ] - Market Wire
ARIAD To Present at the Deutsche Bank 37th Annual Health Care Conference
[ Mon, Apr 30th 2012 ] - Market Wire
Rockwell Medical Completes Patient Enrollment in PRIME Clinical Study
[ Mon, Apr 30th 2012 ] - Market Wire
PolyTouch Medical Acquired by Covidien
[ Mon, Apr 30th 2012 ] - Market Wire
Sangamo BioSciences Nominates Saira Ramasastry To The Company's Board Of Directors
[ Mon, Apr 30th 2012 ] - Market Wire
Novadaq to Present at Deutsche Bank 37th Annual Health Care Conference
[ Mon, Apr 30th 2012 ] - Market Wire
Hologic to Acquire Gen-Probe
[ Mon, Apr 30th 2012 ] - Market Wire
Capital Senior Living Corporation to Present at D .. 37th Annual Health Care Conference on Monday, Ma
[ Mon, Apr 30th 2012 ] - Market Wire
MiMedx Selects Allen amp;; Caron for Inves .. ons, Media Relations and Corporate Communications
Sun, April 29, 2012
[ Sun, Apr 29th 2012 ] - Market Wire
RepliCel Clarifying News Release
[ Sun, Apr 29th 2012 ] - Market Wire
April 30, 2012 at 8:00 am Eastern Time
[ Sun, Apr 29th 2012 ] - Market Wire
Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
[ Sun, Apr 29th 2012 ] - Market Wire
Haemonetics Signs Definitive Agreement to Acquire .. llection, Filtration and Processing Product Lines
Sat, April 28, 2012
[ Sat, Apr 28th 2012 ] - Market Wire
Mylan to Partner with United Nations and Clinton .. to Fight Diarrhea Fatalities in Children in India
Fri, April 27, 2012
[ Fri, Apr 27th 2012 ] - Market Wire
Quest Diagnostics Establishes Unique Healthcare I .. o Vital Patient Health Information;; 80 Mi
[ Fri, Apr 27th 2012 ] - Market Wire
Anthera Announces First Quarter 2012 Financial Report and Conference Call
[ Fri, Apr 27th 2012 ] - Market Wire
PFCD Capitol Hill Roundtable Explores IBM Watson .. logyas Value in Advancing Health Care Innovations
[ Fri, Apr 27th 2012 ] - Market Wire
Los nuevos datos sobre TYSABRI presentados en la .. ia Americana de Neurologa (AAN, por sus siglas en
[ Fri, Apr 27th 2012 ] - Market Wire
Cambrex To Announce First Quarter 2012 Financial Results On May 3, 2012
[ Fri, Apr 27th 2012 ] - Market Wire
Watson adquirir a Actavis Group por 4,25 mil millones de euros
[ Fri, Apr 27th 2012 ] - Market Wire
Valeant Pharmaceuticals to Present at Deutsche Ba .. curities, Inc. 37th Annual Health Care Conference
[ Fri, Apr 27th 2012 ] - Market Wire
MELA Sciences Named 2012 Bronze Edison Award Winner
[ Fri, Apr 27th 2012 ] - Market Wire
LabCorp to Webcast Its Annual Meeting of Stockholders
[ Fri, Apr 27th 2012 ] - Market Wire
Vermillion Board of Directors Unanimously Nominates Paul R. Sohmer, M.D. for Company Director
[ Fri, Apr 27th 2012 ] - Market Wire
XTend Medical Corporation (XMDC) Begins Process to Change Name to MultiCorp International, Inc.
[ Fri, Apr 27th 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation Completes Trea .. RT(TM) Allergic Rhinitis Special Population Study
[ Fri, Apr 27th 2012 ] - Market Wire
Lota S. Zoth Joins Orexigen Therapeutics Board of Directors
[ Fri, Apr 27th 2012 ] - Market Wire
Watson adquiere Actavis Group por 4.250 millones de euros
[ Fri, Apr 27th 2012 ] - Market Wire
Kindred Healthcare Announces Ventas Lease Renewals
[ Fri, Apr 27th 2012 ] - Market Wire
Covidien comunica i risultati del secondo trimestre
[ Fri, Apr 27th 2012 ] - Market Wire
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012
[ Fri, Apr 27th 2012 ] - Market Wire
Crown Dynamics' AIR(R) Product Line Pass Testing
Thu, April 26, 2012
[ Thu, Apr 26th 2012 ] - Market Wire
Johnson amp;; Johnson Holds 2012 Annual Meeting of Shareholders
[ Thu, Apr 26th 2012 ] - Market Wire
Heska Announces First Quarter 2012 Earnings Conference Call Webcast
[ Thu, Apr 26th 2012 ] - Market Wire
Notice of Paladin Labs' First Quarter 2012 Results Conference Call
[ Thu, Apr 26th 2012 ] - Market Wire
Tenet Announces Repurchase of $299 Million of Mandatory Convertible Preferred Stock
[ Thu, Apr 26th 2012 ] - Market Wire
QRxPharma's US Commercialisation Partner, Actavis .. armaceuticals, Inc.: MoxDuo IR on track for launc
[ Thu, Apr 26th 2012 ] - Market Wire
Low Side Effects Seen in Treatment With Delcath's Second Generation Hemofiltration Cartridge
[ Thu, Apr 26th 2012 ] - Market Wire
Cytokinetics Announces Presentation of Preclinica .. t the 2012 Experimental Biology Annual Conference
[ Thu, Apr 26th 2012 ] - Market Wire
Stem Cell Therapeutics Reports 2011 Year End Results
[ Thu, Apr 26th 2012 ] - Market Wire
Incyte Reports 2012 First-Quarter Financial Resul .. ers on Commercial Activity and Key Clinical Progr
[ Thu, Apr 26th 2012 ] - Market Wire
Amylin Pharmaceuticals Reports First Quarter 2012 Financial Results
[ Thu, Apr 26th 2012 ] - Market Wire
Celgene Reports First Quarter 2012 Operating and Financial Results
[ Thu, Apr 26th 2012 ] - Market Wire
Invacare Corporation Announces Financial Results for the First Quarter of 2012
[ Thu, Apr 26th 2012 ] - Market Wire
Watson acquiert le groupe Actavis pour 4,25 Milliards d'Euros
[ Thu, Apr 26th 2012 ] - Market Wire
Watson to Acquire Actavis Group for EUR 4.25 Billion
[ Thu, Apr 26th 2012 ] - Market Wire
Shire Reports Positive Phase 2 Study Met Primary .. se of Vyvanse (lisdexamfetamine dimesylate) Capsu
[ Thu, Apr 26th 2012 ] - Market Wire
Simcere Pharmaceutical Group Filed 2011 Annual Report on Form 20-F
[ Thu, Apr 26th 2012 ] - Market Wire
Forest Laboratories, Inc. and Pierre Fabre Medica .. Phase III Study for Levomilnacipran in Patients w
Wed, April 25, 2012
[ Wed, Apr 25th 2012 ] - Market Wire
Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
[ Wed, Apr 25th 2012 ] - Market Wire
DiversityInc Names Lilly a Top Company for Diversity
[ Wed, Apr 25th 2012 ] - Market Wire
AstraZeneca and The Medicines Company Announce Gl .. bal Collaboration in Acute Ischemic Heart Disease
[ Wed, Apr 25th 2012 ] - Market Wire
ProMetic Receives $1.9 Million Follow-On Order From a US Based Biopharmaceutical Company
[ Wed, Apr 25th 2012 ] - Market Wire
Gentiva Health Services To Present at Deutsche Bank and Bank of America Merrill Lynch Conferences
[ Wed, Apr 25th 2012 ] - Market Wire
IGSM Discusses EarthStream.TV Next Generation
[ Wed, Apr 25th 2012 ] - Market Wire
Targacept Announces Reduction in Force and Plan to Focus Resources on Later-Stage Pipeline
[ Wed, Apr 25th 2012 ] - Market Wire
Providence Service Corporation to Report First Qu .. lts on Wednesday, May 9th After the Market Closes
[ Wed, Apr 25th 2012 ] - Market Wire
BIOLASE Files Patent Infringement Lawsuit Against European Competitor
[ Wed, Apr 25th 2012 ] - Market Wire
Lpath Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab
[ Wed, Apr 25th 2012 ] - Market Wire
VistaGen Secures Key U.S. Patent Covering Stem Ce .. s Used to Test Drug Candidates for Liver Toxicity
[ Wed, Apr 25th 2012 ] - Market Wire
AVI BioPharma to Present Additional Data From the .. n for the Treatment of Duchenne Muscular Dystroph
[ Wed, Apr 25th 2012 ] - Market Wire
Cantel Medical Appoints Seth M. Yellin As Vice President Of Corporate Development
[ Wed, Apr 25th 2012 ] - Market Wire
Humana Military Named in the Top 25 for Military Timesa 2012 aBest Employers for Vetsa
[ Wed, Apr 25th 2012 ] - Market Wire
ARIAD to Webcast Conference Call on First Quarter 2012 Financial Results
[ Wed, Apr 25th 2012 ] - Market Wire
Threshold Pharmaceuticals Appoints Robert Simon as Senior Vice President of Regulatory Affairs
[ Wed, Apr 25th 2012 ] - Market Wire
HeartWare Stock Trading Halted Today;; FDA .. w HeartWare Ventricular Assist System as a Bridge

Medivation Announces First Quarter 2012 Financial Results Teleconference on May 8, 2012


//health-fitness.news-articles.net/content/2012/ .. ancial-results-teleconference-on-may-8-2012.html
Published in Health and Fitness on Tuesday, May 1st 2012 at 11:38 GMT by Market Wire   Print publication without navigation


May 01, 2012 14:25 ET

Medivation Announces First Quarter 2012 Financial Results Teleconference on May 8, 2012

SAN FRANCISCO, CA--(Marketwire - May 1, 2012) - Medivation, Inc. (NASDAQ: [ MDVN ]) today announced that it will host a live teleconference with management to discuss first quarter 2012 financial results and provide a general business update on Tuesday, May 8, 2012 at 4:30 p.m. Eastern Time. A press release for the first quarter of 2012 will be released after markets close on May 8, 2012.

Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partner Astellas, Medivation currently has the investigational drug MDV3100 in Phase 3 development to treat advanced prostate cancer. For more information, please visit us at [ www.medivation.com ].



Publication Contributing Sources